Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Globes) Gali Weinreb - An FDA-approved treatment for cholesterol could dramatically ease the symptoms of Covid-19, the Hebrew University of Jerusalem reports. Prof. Yaakov Nahmias, director of the Grass Center for Bioengineering, found that the drug Fenofibrate could inhibit Covid-19's ability to reproduce in lung cells. Prof. Nahmias said, "If our results are confirmed in clinical trials, then within a few months, treatment with our drug could be turning Covid-19 into a type of common cold." 2020-07-16 00:00:00Full Article
Hebrew U.: FDA-Approved Drug Could Dramatically Ease Covid-19 Symptoms
(Globes) Gali Weinreb - An FDA-approved treatment for cholesterol could dramatically ease the symptoms of Covid-19, the Hebrew University of Jerusalem reports. Prof. Yaakov Nahmias, director of the Grass Center for Bioengineering, found that the drug Fenofibrate could inhibit Covid-19's ability to reproduce in lung cells. Prof. Nahmias said, "If our results are confirmed in clinical trials, then within a few months, treatment with our drug could be turning Covid-19 into a type of common cold." 2020-07-16 00:00:00Full Article
Search Daily Alert
|
Search:
|